Rapid
tests
for
detection
of
carbapenemase
producers
in
P.
aeruginosa;
what
do
we
really
need?
Pruebas
rápidas
para
la
detección
de
Pseudomonas
aeruginosa
productora
de
carbapenemasas.
¿Qué
necesitamos
realmente?
Laurent
Poirel
a,b,c,∗,
Patrice
Nordmann
a,b,c,daINSERMU914“EmergingResistancetoAntibiotics”,France
bMedicalandMolecularMicrobiology,DepartmentofMedicine,FacultyofScience,UniversityofFribourg,Switzerland
cCentreNationalAssocié-CentredeRéférencedesRésistancesauxAntibiotiques,LeKremlin-Bicêtre,France
dHopitalFribourgeois-hôpitalCantonal,Fribourg,Switzerland
Resistance to carbapenems in Pseudomonas aeruginosa is a majorissue sincethat species is intrinsicallyresistant tomany antibiotics and therefore, as soon as some acquired resistance traitsoccur,carbapenemsbecomerapidlytheultimate therapeu-tic options.1 Carbapenem resistancein P.aeruginosamay occur throughthelossofanouter-membraneproteinnamedOprDthat resultsfrommutationsortruncationsinthecorrespondinggene.2 InEurope,thatmechanismaccountsfor15–20%ofthe imipenem-resistantP.aeruginosa isolates.Itis nottransmissiblesinceit is chromosomally-encodedandinterfereswithimipenem suscepti-bilityonly,meropenemanddoripenemaswellasbroad-spectrum cephalosporinsremainingeffectiveagainstOprD-deficientstrains (ifnoadditionalacquiredmechanism).However,theacquisitionof carbapenemasegenesisanothermechanismofcarbapenem resis-tanceinP.aeruginosathatis increasinglyidentified wordwide.3 That resistance trait is more worrisome since it corresponds to genes acquired through horizontal gene transfers that may disseminate, and impacts all carbapenem molecules that are all hydrolyzed by those enzymes. In P. aeruginosa, carbapene-mases are mainly metallo--lactamases (MBLs) that hydrolyze allcarbapenems very efficiently.4 They arenot inhibited by -lactamaseinhibitorssuchasclavulanicacidandtazobactamand alsoconferresistancetoother-lactamssuchasbroad-spectrum cephalosporins.
Therefore,anaccurateandrapiddetectionofcarbapenemase production in P. aeruginosa is extremely important. Such rapid detectionmaycontributetofacilitatetheantibioticstewardship andtreatmentofinfectedpatientsandtopreventthefurtherspread ofthosecarbapenem-resistantisolates.
Therefore,inorder tooptimizeinfectioncontroland antimi-crobialtherapy, advancesindetection methodsare crucial.Use
∗ Correspondingauthor.
E-mailaddress:laurent.poirel@unifr.ch(L.Poirel).
of molecularbiology and in particular PCR-based techniquesis beingthe key-approachfor rapidand accurateidentificationof those resistancetraits.Themain advantagesof molecular tech-niquesaresensitivity,specificity,andtherelativerapidityofthese methods.Without moleculartechniquesin routinelaboratories, identification of resistance mechanisms is often fastidious and time-consuming.
However,therearesomedrawbackswiththosemolecular tech-niques,themainonesare:(i)theyareexpensive,(ii)theydorequire somesignificantexpertise,(iii)theydonotfullyreplacethe antibi-ogramsincetheyonlytargetsomespecificmoleculardeterminants butdonotevaluatetherealsusceptibilityoftheisolatetoalarge varietyofdrugs,(iv)thecorrelationbetweengeneidentification andresistanceisnotalwaysobserved(geneexpressionand mod-ulation),and(v)bydefinitiontheydonotidentifythenoveland emergingresistancegenes.
Thatisthereasonwhybiochemicalandphenotypicalmethods havestilltobeconsideredasinterestingtools.Inthestudy per-formedbyLucenaetal.inthisissue,5phenotypictestsfordetection ofMBLproductionhavebeencomparedwithanimpressive collec-tionofmetallo--lactamaseproducers,mostlyoftheSPMtype.The double-disksynergytest(DDST),theCombined-Disk(CD)assay, andtheMBLE-testhavebeencompared.Theyallshowsome advan-tagesanddisadvantages,butonemainshortcomingisthelackof clearcut-offtoaccuratelyinterprettheobtainedresults. Depend-ingonthestrainbackground(additionalresistancemechanismsor not),andontheuser’stechnicalskills,variableresultsand inter-pretationsmaybeobserved.
We believe that those diagnostic techniques,in order to be used,mustnotonlybeaffordableandrapid,butoverallmustbe easy toperformand interpret. Routinelaboratoriescannotrely oncomplicatedscreeningstrategiesthat,inaddition,mayprovide difficult-to-interpretresults.Effortsmustbeplacedindeveloping thoseteststhatmaybeusedinanyclinicallaboratory,andnotonly inthosewithadvancedtechnologiesorhighlyqualifiedpersonal.
1
Published in (QIHUPHGDGHV,QIHFFLRVDV\0LFURELRORJtD&OtQLFD
±
which should be cited to refer to this work.
One recently developed technique aiming to rapidly iden-tifycarbapenemaseproducers,eitherinPseudomonasspp.andin Enterobacteriaceae, is theCarba NP test that corresponds to an efficient and reliable diagnostic tool for identification of those enzymes.6Themainadvantagesofthistestarethatitisextremely rapidandcostless,bycontrasttomostoftheotherknown tech-niques. It actually represents a breakthrough for detection of carbapenemaseproducerswithresultsobtainedinlessthantwo hours,eitherdirectlyfromcoloniesbutalsofromclinicalsamples suchasbloodculturesandurines.7,8Anothermajoradvantageof thistestisthatitcanbeimplementedinanyclinicallaboratories due toitssimplicity.Itistherefore welladapted tothecurrent needs, i.e. improvingthehygiene controland theantimicrobial therapy.InacountrysuchasBrazilwherethestudyfromLucena etal.hasbeenperformed,5itmightreallyprovideanadded-value since notonlyitslowpriceandlow-expertiserequirementwill surelyfittotheexpectations,butalsothecurrentandvery worri-someepidemiology(withhugedisseminationofSPM-1-producing P.aeruginosastrainsalloverthecountry9,10)willmakeitan essen-tialtool.
Public healthauthorities aroundtheworldpromptto estab-lishguidelinesrecommendingstrictandaccuratemonitoringof antimicrobialresistanceshouldfacilitatethedevelopmentand dis-seminationofthosekindsofmethodsthatcorrespondtotheneeds inthe“real”dailylife.
References
1.NordmannP,NaasT,FortineauN,PoirelL.Superbugsinthecomingnewdecade; multidrugresistanceandprospectsfortreatmentofStaphylococcusaureus, Enterococcusspp.andPseudomonasaeruginosain2010.CurrOpinMicrobiol. 2007;10:436–40.
2.NordmannP.Gram-negativebacteriawithresistancetocarbapenems.MedSci (Paris).2010;26:950–9.
3.PoirelL,PitoutJD,NordmannP.Carbapenemases:moleculardiversityand clin-icalconsequences.FutureMicrobiol.2007;2:501–12.
4.WalshTR,TolemanMA,PoirelL,NordmannP.Metallo--lactamases:thequiet beforethestorm?ClinMicrobiolRev.2005;18:306–25.
5.LucenaA,DallaCostaLM,DaSilvaNogueiraK,MatosAP,GalesAC,Raboni SM.Comparisonofphenotypictestsforthedetectionofmetallo--lactamases inclinicalisolatesofPseudomonasaeruginosa.EnfermInfectMicrobiolClin. 2014;32:625–30.
6.NordmannP,PoirelL,DortetL.Rapiddetectionofcarbapenemase-producing Enterobacteriaceae.EmergInfectDis.2012;18:1503–7.
7.DortetL, Bréchard L, Cuzon G, PoirelL, Nordmann P.Strategy for rapid detectionofcarbapenemase-producingEnterobacteriaceae.AntimicrobAgents Chemother.2014;58:2441–5.
8.DortetL,BréchardL,PoirelL,NordmannP.Rapiddetectionof carbapenemase-producing Enterobacteriaceae from blood cultures. Clin Microbiol Infect. 2014;20:340–4.
9.GalesAC,MenezesLC,SilbertS,SaderHS.Disseminationindistinct Brazil-ian regionsof an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo--lactamase. J Antimicrob Chemother. 2003;52: 699–702.
10.Poirel L, Magalhaes M, Lopes M, Nordmann P. Molecular analysis of metallo--lactamasegeneblaSPM-1-surroundingsequencesfromdisseminated
PseudomonasaeruginosaisolatesinRecife,Brazil.AntimicrobAgentsChemother. 2004;48:1406–9.
2